Johnson & Johnson (J&J) has announced that Fortive Corp has made an offer of about $2.7 billion in cash for its Advanced Sterilisation Products (ASP) business.
Europe’s medicines regulator is expecting higher-than-anticipated staff departures as a result of its Brexit-induced move from London to Amsterdam next year.
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.